Nemaura Medical Inc. (NMRD): Price and Financial Metrics
NMRD Price/Volume Stats
Current price | $0.08 | 52-week high | $1.25 |
Prev. close | $0.08 | 52-week low | $0.07 |
Day low | $0.08 | Volume | 13,000 |
Day high | $0.09 | Avg. volume | 108,485 |
50-day MA | $0.08 | Dividend yield | N/A |
200-day MA | $0.39 | Market Cap | 2.31M |
NMRD Stock Price Chart Interactive Chart >
NMRD Stock Summary
- With a market capitalization of $3,699,123, NEMAURA MEDICAL INC has a greater market value than just 1.91% of US stocks.
- With a price/sales ratio of 1,226.09, NEMAURA MEDICAL INC has a higher such ratio than 99.38% of stocks in our set.
- Revenue growth over the past 12 months for NEMAURA MEDICAL INC comes in at -99.48%, a number that bests merely 0.79% of the US stocks we're tracking.
- Stocks that are quantitatively similar to NMRD, based on their financial statements, market capitalization, and price volatility, are ENVA, FMC, EMN, GTH, and OPGN.
- Visit NMRD's SEC page to see the company's official filings. To visit the company's web site, go to nemauramedical.com.
NMRD Valuation Summary
- In comparison to the median Healthcare stock, NMRD's price/earnings ratio is 102.06% lower, now standing at -0.6.
- NMRD's EV/EBIT ratio has moved up 847.5 over the prior 110 months.
Below are key valuation metrics over time for NMRD.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
NMRD | 2023-12-29 | 2100.0 | -0.4 | -0.6 | -4.2 |
NMRD | 2023-12-28 | 2333.3 | -0.4 | -0.7 | -4.4 |
NMRD | 2023-12-27 | 1933.3 | -0.4 | -0.6 | -4.1 |
NMRD | 2023-12-26 | 1733.3 | -0.3 | -0.5 | -4.0 |
NMRD | 2023-12-22 | 1733.3 | -0.3 | -0.5 | -4.0 |
NMRD | 2023-12-21 | 1666.7 | -0.3 | -0.5 | -4.0 |
NMRD Growth Metrics
- Its 4 year price growth rate is now at -82.5%.
- Its 3 year net cashflow from operations growth rate is now at -82.65%.
- Its 2 year net cashflow from operations growth rate is now at -88.55%.
The table below shows NMRD's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 0.397322 | -8.240728 | -13.07814 |
2022-09-30 | 0.577933 | -7.577046 | -15.10659 |
2022-06-30 | 0.503906 | -7.198156 | -14.52238 |
2022-03-31 | 0.503906 | -6.504041 | -13.88681 |
2021-12-31 | 0.183628 | -5.712827 | -12.40018 |
2021-09-30 | 0 | -6.467909 | -10.41531 |
NMRD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- NMRD has a Quality Grade of D, ranking ahead of 8.07% of graded US stocks.
- NMRD's asset turnover comes in at 0 -- ranking 171st of 185 Medical Equipment stocks.
- SNN, EYE, and BAX are the stocks whose asset turnover ratios are most correlated with NMRD.
The table below shows NMRD's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0 | NA | -0.496 |
2021-03-31 | 0 | NA | -0.595 |
2020-12-31 | 0 | NA | -1.908 |
2020-09-30 | 0 | NA | -2.821 |
2020-06-30 | 0 | NA | -6.854 |
2020-03-31 | 0 | NA | 9.198 |
NMRD Price Target
For more insight on analysts targets of NMRD, see our NMRD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $15.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
Nemaura Medical Inc. (NMRD) Company Bio
Nemaura Medical Inc. designs and develops proprietary drug delivery platforms. The Company produces therapeutic delivery systems including patches and injectors. Nemaura Medical offers its products to the pharmaceutical and healthcare industries.
Latest NMRD News From Around the Web
Below are the latest news stories about NEMAURA MEDICAL INC that investors may wish to consider to help them evaluate NMRD as an investment opportunity.
Nemaura Medical Inc. Receives Positive Nasdaq Listing DecisionLoughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce that the Nasdaq Hearings Panel granted the Company’s request for continued listing pursuant to an exception, including certain interim milestones, that ultimately expires on April 1st, 2024, to evidence compliance with all applicable criteria for continued listing |
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic GrowthLoughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce the execution of a strategic agreement for a $10 million credit facility which is expected to support the Company’s strategic growth plans. Recognizing the challenges associated with equity sales, particularly in the small-cap landscape on the Nasdaq, Nemaura Medi |
Nemaura (NMRD) to Expand in UK With Metabolic Health ProgramThe latest program leverages Nemaura's (NMRD) world-first daily wear non-invasive CGM technology, providing individuals with real-time insights into their body's glucose dynamics. |
Nemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)Nemaura Medical ( NASDAQ:NMRD ) First Half 2024 Results Key Financial Results Net loss: US$3.81m (loss narrowed by 52... |
Sidoti Events, LLC’s Virtual November Micro-Cap ConferenceNEW YORK, NY / ACCESSWIRE / November 14, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day November Micro-Cap Conference taking place Wednesday and Thursday, November ... |
NMRD Price Returns
1-mo | -3.61% |
3-mo | -52.66% |
6-mo | -79.12% |
1-year | -88.98% |
3-year | -99.02% |
5-year | -99.22% |
YTD | -63.47% |
2023 | -87.25% |
2022 | -62.34% |
2021 | 20.95% |
2020 | 7.71% |
2019 | -61.11% |
Loading social stream, please wait...